The largest database of trusted experimental protocols

Erα sp1

Manufactured by Thermo Fisher Scientific
Sourced in United Kingdom

ERα (SP1) is a lab instrument produced by Thermo Fisher Scientific. It is designed to detect and measure the presence of the Estrogen Receptor alpha (ERα) protein in biological samples. The core function of this product is to provide researchers with a tool for analyzing the expression levels of this specific protein, which is important in various areas of biological and medical research.

Automatically generated - may contain errors

4 protocols using erα sp1

1

Breast Cancer Cell Line Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
DMSO, E2 and TAM were obtained from Sigma-Aldrich (St. Louis, MO USA). RAL (Evista®, Eli Lilly and Company, Indianapolis, IN USA) was purchased from the University of Illinois at Chicago Hospital Pharmacy. Cell culture reagents were obtained from Life Technologies (Carlsbad, CA USA). Tissue culture plasticware was purchased from Becton-Dickinson (Franklin Lakes, NJ USA). The following antibodies were used: rabbit polyclonal PKCα (C-20, Santa Cruz Biotechnology, Dallas, TX USA), rabbit polyclonal ERα (SP1, Lab Vision, Thermo Scientific, Kalamazoo, MI USA), mouse monoclonal β-actin (Sigma, St. Louis, MO USA), anti-rabbit Alexa Fluor 488 (Life Technologies, Carlsbad, CA USA) and anti-mouse Cy3 (Jackson Immunoresearch Laboratories, West Grove, PA).
+ Open protocol
+ Expand
2

Monoclonal Antibody Generation against BIG3

Check if the same lab product or an alternative is used in the 5 most similar protocols
The anti-BIG3 monoclonal antibody was generated by Sigma-Aldrich (Tokyo, Japan). Briefly, a rat was immunised with purified His-tagged human BIG3 protein (459-572 aa). The iliac lymph nodes were collected and fused with myeloma cells, resulting in the formation of a hybridoma. Immunoblot analyses were performed as described previously9 (link). After SDS-PAGE, the membranes blotted with proteins were blocked with 4% BlockAce solution (Dainippon Pharmaceutical, Osaka, Japan) for 1 h and then incubated with antibodies against the following proteins: BIG3 (1:1,000); PHB2 (1:1,000, Abcam, Cambridge, UK); ERα (SP-1, 1:500, Thermo Fisher Scientific, Fremont, CA, USA); Akt, phospho-Akt (S473) (587F11, 1:1,000), p44/42 MAPK, phospho-p44/42 MAPK (T202/Y204) (1:1,000), VCP (valosin-containing protein) (1:500), and α/β-tubulin (1:1,000) (Cell Signaling Technology, Danvers, MA, USA); β-actin (AC-15; 1:5,000) and LMNB1 (1:100; Sigma) using standard procedures. All of the experiments were performed in triplicate at a minimum.
+ Open protocol
+ Expand
3

Immunocytochemistry for Breast Cancer Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
For immunocytochemistry (ICC), 1–2 × 105 cells were seeded onto glass coverslips in 6-well plates in regular media. For assessing PR, cells were treated with 10 nM E2 for 48 h prior to collection. Cells were washed twice with PBS and fixed with ice-cold 70% acetone/30% methanol for 5 min. Fixed cells were blocked with 10% normal goat serum (Vector Labs, Burlingame, CA) in 0.05% TBS-T for 30 min. Primary antibodies were as follows: ERα (SP1, 1:200, Thermo-Fisher, Waltham, MA), PR (1294, 1:50, [26 (link)], CK5 (ab75869, 1:400, Abcam, Cambridge, MA), CK8/18 (NCL-L-5D3, 1:2000, Leica Biosystems), and Vimentin (5741, 1100, Cell Signaling, Danvers, MA) for 1 h. Secondary antibodies were A11029 (green) and/or A11037 (red) (Invitrogen, 1:200) for 30 min followed by counterstaining with 0.1 μg/mL DAPI. Phase contrast images were captured using a Nikon TiE microscope (Nikon, Melville, NY) equipped with a digital camera and NIS Elements 4.6 software. Fluorescent images were captured using an Olympus BX40 microscope equipped with a digital camera and cellSens Standard 1.13 software. Adobe Photoshop CC 2019 was used to perform minimal linear adjustments to brightness/contrast and to assemble pictures into multipanel figures. Immunohistochemistry (IHC) of PDX was performed with the same antibodies for the indicated markers as previously described [21 (link)].
+ Open protocol
+ Expand
4

Molecular Analysis of Protein Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
SDS-PAGE and immunoblot analyses were performed as described previously,21 (link) with antibodies against the following proteins: PHB2 (1:1000), ERα (phospho Y537; 1:500), ErbB2/HER2 and phosphor-HER2 (pY877) (Abcam, Cambridge, UK); ERα (SP-1, 1:500; Thermo Fisher Scientific, Fremont, CA, USA); Akt, phospho-Akt (S473) (587F11, 1:1000), p44/42 MAPK, phospho-p44/42 MAPK (T202/Y204) (1:1,000), Shc (1:500), phospho-Shc (Tyr239/240) (1H12, 1:500), phospho-ERα (S104/S106; 1:500), IGF-1Rβ (1:500), phospho-IGF-1Rβ (Y1135/1136) (19H7, 1:500), EGFR (1:1000) and phospho-EGFR (Tyr1068) (1:500) (Cell Signaling Technology); PI3-kinase p85α (U13; 1:500) and phospho-ERα (S118; 1:500) (Santa Cruz Biotechnology, Santa Cruz, CA, USA); phospho-ERα (S167) (1:500) and phospho-ERα (S305) (1:500) (Merck Millipore, Billerica, MA, USA); phosphotyrosine (1:500) (Life Technologies, Rockville, MD, USA); and β-actin (AC-15; 1:5000) (Sigma). All of the experiments were performed in triplicate at minimum.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!